US 10849875
Cancer specific lipid targeted peptidomimetics
granted A61KA61K31/337A61K31/343
Quick answer
US patent 10849875 (Cancer specific lipid targeted peptidomimetics) held by The Board of Regents of the University of Texas System expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/337, A61K31/343, A61K38/00, A61K47/55